Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-051126
Filing Date
2024-12-13
Accepted
2024-12-13 08:18:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 primemedicine-sx3shelf.htm S-3 211633
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 28498
3 EX-5.1 exhibit51-sx3.htm EX-5.1 6020
4 EX-23.1 exhibit231-sx3.htm EX-23.1 1890
5 primemedicinelogo.jpg GRAPHIC 6454
6 primemedicinelogoa.jpg GRAPHIC 21462
  Complete submission text file 0001628280-24-051126.txt   287745
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283780 | Film No.: 241546871
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)